Skip to main content
TipRanks
Go Ultimate75% OFF

Nagaileben Co., Ltd. (7447) AI Stock Analysis

0 Followers
JP:7447

Nagaileben Co., Ltd.

(TSE/TYO:7447)

Select Model
Rating:70Outperform
Price Target:JPY 1,799.00â–²(5.39% Upside)
Action:reiterated
Date:10/02/26

The score is primarily driven by strong financial resilience (notably a debt-free balance sheet) and solid profitability, supported by an attractive dividend yield. These positives are partially offset by weak technical momentum and a multi-year trend of easing margins/earnings with historically volatile cash-flow consistency.

Positive Factors
Debt-free balance sheetA debt-free balance sheet materially lowers financial risk and preserves flexibility during weaker operating periods. The sizable equity base also provides capacity to support operations, maintain shareholder distributions, or fund investments without relying heavily on borrowing.
Negative Factors
Multi-year margin and earnings compressionThe decline in net income and multi-year margin compression indicate that earlier earnings strength has not been fully sustained. If this pattern persists, it could reduce reinvestment capacity and weaken the company’s ability to translate stable sales into durable profit growth.

Nagaileben Co., Ltd. (7447) vs. iShares MSCI Japan ETF (EWJ)

-20%-10%0%10%20%30%JP:7447-4.37%EWJ+18.48%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 51.16B
Dividend Yield
4.10%
Average Volume (3M)
112.38K
Price to Earnings (P/E)
19.4
Beta (1Y)
0.53
Revenue Growth
1.31%
EPS Growth
6.19%
Country
Japan
Employees
501
Sector
Consumer Cyclical
Sector Strength
61
Industry
Apparel - Manufacturers

Nagaileben Co., Ltd. Business Overview & Revenue Model

Company Description

Nagaileben Co., Ltd. is a Japanese enterprise that manufactures and distributes apparel for the medical industry. Their product range includes specialized clothing for hospitals, clinics, and operating rooms. This company was established in 1915 and...

How the Company Makes Money

Nagaileben makes money mainly by selling uniforms and related apparel, with revenue recognized from product sales to business-to-business customers and distribution partners. Key revenue streams typically include (1) institutional and corporate sales...

Nagaileben Co., Ltd. Financial Statement Overview

Summary

Financial risk is low and resilience is high due to a debt-free balance sheet and solid ongoing profitability (healthy gross/operating/net margins). Offsetting this strength are signs of multi-year margin and earnings compression and historically uneven cash-flow consistency despite a strong most-recent year.

Income Statement

76Positive

Balance Sheet

92Very Positive

Cash Flow

74Positive
Financial statement breakdown
BreakdownTTMAug 2026Aug 2025Aug 2024Aug 2023Aug 2022
Income Statement
Total Revenue17.21B17.21B16.98B16.41B17.18B17.75B
Gross Profit6.89B6.73B6.57B6.90B7.41B7.72B
EBITDA4.04B3.92B3.86B4.27B4.88B5.31B
Net Income2.65B2.65B2.57B2.82B3.23B3.78B
Balance Sheet
Total Assets42.19B42.19B44.77B46.76B47.41B47.40B
Cash, Cash Equivalents and Short-Term Investments22.40B22.40B24.25B26.35B27.16B28.56B
Total Debt000000
Total Liabilities3.14B3.14B3.45B4.06B4.19B5.14B
Stockholders Equity39.06B39.06B41.32B42.70B43.21B42.26B
Cash Flow
Free Cash Flow03.31B1.89B2.14B1.55B3.35B
Operating Cash Flow03.53B2.18B2.29B1.81B3.44B
Investing Cash Flow01.67B1.11B-1.77B3.42B-471.43M
Financing Cash Flow0-5.05B-3.89B-2.93B-2.94B-3.20B

Nagaileben Co., Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price1707.00

Price Trends

50DMA1676.74Positive
100DMA1677.27Positive
200DMA1666.10Positive

Market Momentum

MACD4.81Negative
RSI54.07Neutral
STOCH41.45Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7447, the sentiment is Positive. The current price of 1707.00 is above the 20-day moving average (MA) of 1687.90, above the 50-day MA of 1676.74, and above the 200-day MA of 1666.10, indicating a bullish trend. The MACD of 4.81 indicates Negative momentum. The RSI at 54.07 is Neutral, neither overbought nor oversold. The STOCH value of 41.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7447.

Nagaileben Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

JP:7447 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:3569JP:356975OutperformJPY 194.22B13.419.85%2.24%16.78%5.60%
JP:3201JP:320172OutperformJPY 127.53B13.06―2.31%-0.33%40.20%
JP:7447JP:744770OutperformJPY 51.13B19.43―4.10%1.31%6.19%
JP:3104JP:310466NeutralJPY 99.38B15.23―2.62%14.36%22.61%
JP:3580JP:358066NeutralJPY 25.71B10.11―4.02%0.56%82.80%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
JP:3002JP:300259NeutralJPY 130.10B25.414.97%4.92%-3.94%113.82%

* Consumer Cyclical Sector Average

Performance Comparison

0%25%50%75%100%JP:7447JP:3002JP:3569JP:3104JP:3201JP:3580Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7447 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7447Nagaileben Co., Ltd.1707.00-97.23-5.39%
JP:3002Gunze 4390.00694.6018.80%
JP:3569Seiren Co 3620.00641.6721.54%
JP:3104Fujibo Holdings, Inc.2940.00759.2634.82%
JP:3201Japan Wool Textile Co., Ltd.2076.00478.1629.93%
JP:3580KOMATSU MATERE Co., Ltd.672.00-105.35-13.55%

Nagaileben Co., Ltd. Corporate Events

Nagaileben Launches ¥1 Billion Share Buyback to Bolster Shareholder Value

Oct 1, 2026

Nagaileben Co., Ltd., listed on the Tokyo Stock Exchange’s Prime Market, operates in the Japanese corporate sector with an emphasis on disciplined capital management and shareholder-focused policies. The company has consistently highlighted sharehold...

Nagaileben Posts Modest Profit Growth and Strong Balance Sheet, Signals Stable Outlook

Oct 1, 2026

Nagaileben Co., Ltd., a Tokyo-listed manufacturer of medical and professional apparel, reported modest growth for the fiscal year ended August 31, 2026, with net sales rising 1.3% to ¥17.2 billion and profit attributable to owners of the parent up 3....

Nagaileben Tightens Internal Control and Group Governance Framework

Sep 1, 2026

Nagaileben Co., Ltd. announced that its Board of Directors has approved a partial revision of its Basic Policy for Internal Control Systems, strengthening frameworks for legal compliance, risk management, and efficient decision-making. The updated po...

Nagaileben Nears Completion of ¥1 Billion Share Buyback Program

Aug 17, 2026

Nagaileben Co., Ltd. has completed a share repurchase program authorized by its board in late June, buying back 157,900 common shares between August 1 and August 12, 2026 via market purchases on the Tokyo Stock Exchange, at a total cost of approximat...

Nagaileben Advances Share Buyback, Repurchases Over 400,000 Shares

Aug 3, 2026

Nagaileben Co., Ltd. has been repurchasing its own common shares under a Board-approved program authorized on June 29, 2026, in accordance with provisions of the Companies Act. Between July 1 and July 31, 2026, the company acquired 360,400 shares thr...

Nagaileben Overhauls Governance With New Executive Officer System and Leaner Board

Jul 14, 2026

Nagaileben Co., Ltd. will introduce an Executive Officer system from September 1, 2026, aiming to respond more swiftly to changes in its business environment and to strengthen corporate governance. Under this framework, executive appointments and dis...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 02, 2026